Budesonide and Venofer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Venofer (iron sucrose). Common drug interactions include flatulence among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Venofer. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Venofer?

Venofer has active ingredients of iron sucrose. It is often used in anemia. eHealthMe is studying from 8,895 Venofer users. Check the latest studies of Venofer.

On Jul, 27, 2026

70 people who take Budesonide and Venofer together, and have interactions are studied.

Budesonide and Venofer drug interactions.

What are the common drug interactions of Budesonide and Venofer, by gender? *:

female:

Flatulence (flatus expelled through the anus)
Frequent bowel movements
Haematochezia (passage of stools containing blood)
Malaise (a feeling of general discomfort or uneasiness)
Menopausal symptoms
Mucous stools (mucous with stool)
Nausea (feeling of having an urge to vomit)
Septic shock (shock due to blood infection)
Spinal fracture (fracture in one of vertebrae)
Swelling

male:

Acute respiratory failure
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Appendicitis (inflammation of the appendix)
Blood beta-d-glucan increased
Blood creatinine increased
Blood pressure decreased
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
C-reactive protein increased
Device related infection
Drug dependence

What are the common drug interactions of Budesonide and Venofer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Septic shock (shock due to blood infection)
Appendicitis (inflammation of the appendix)
Blood beta-d-glucan increased
Blood pressure decreased
C-reactive protein increased
Diarrhoea
Drug dependence
Drug level below therapeutic
Fatigue (feeling of tiredness)
Feeling cold

20-29:

Abdominal distension
Abdominal pain
C-reactive protein decreased
Dehydration (dryness resulting from the removal of water)
Drug ineffective
Fistula (an abnormal connection or passageway between two)
Gastrointestinal inflammation (inflammation of stomach and intestine)
Gastrointestinal obstruction
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

30-39:

Pyrexia (fever)

40-49:

Abdominal pain
Anal abscess
Drug intolerance (drug sensitivity)
Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
Pruritus (severe itching of the skin)
Arthralgia (joint pain)
Breast cancer
Drug ineffective
Nausea (feeling of having an urge to vomit)
Pneumonia

50-59:

Depression
Device related infection
Diabetic foot
Essential hypertension (primary hypertension)
Fatigue (feeling of tiredness)
Glaucoma (increased fluid pressure in the eye with vision loss)
Herpes zoster
Humerus fracture (injury to the upper arm bone)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hyperthyroidism (over activity of the thyroid gland)

60+:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Acute respiratory failure
Productive cough
Blood iron decreased
Blood pressure diastolic decreased
Blood pressure fluctuation
Blood pressure systolic increased
Cardiac disorder
Cardiac failure
Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 25 people, 35.71%
Iron Deficiency Anaemia: 9 people, 12.86%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 11.43%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 7 people, 10.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 8.57%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 8.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.57%
Insomnia (sleeplessness): 6 people, 8.57%
Pain: 6 people, 8.57%
Anaemia (lack of blood): 6 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Venofer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously